1Peto J, Hodgson JT, Matthews FE, et al. Continuing increase in mesothelioma mortality in Britain[J]. Lancet, 1995,345(8959):535～539.
2Yates DH, Corrin B, Stidolph PN, et al. Malignant mesothelioma in south east England: clinicopathological experience of 272 cases[J]. Thorax, 1997,52(11):507～512.
3Adams RF, Gray W, Davies RJ, et al. Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma[J]. Chest ,2001,120:1798～1802.
4Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients[J]. Part 1. Diagnosis. Cancer ,1993,72(2):389～393.
5Sugarbaker DJ, Garcia JP, Richards WG, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients[J]. Ann Surg,1996,224 (3):288～294.
6Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions[J]. Cochrane Database Syst Rev, 2004,(1):CD002916.
7Pass HI, Temeck BK,Kranda K,et al. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma[J]. Ann Surg Oncol,1997 ,4(8):628～633.
8Rusch VW, Venkatraman F. The importance of surgical staging in the treatment of malignant pleural mesothelioma[J]. J Thorac Cardiovasc Surg ,1996,111:815～825.
9Sugarbaker DJ, Jaklittsch MT, BuenoR. Prevention, early detection, and management of complication after 328 consecutive extrapleural pneumonectomise[J]. J Thorac Cardiovasc Surg, 2004,128(1):138～146.
10Berghmans T, Paesmans M, Lalami Y. et al. Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis[J]. Lung Cancer, 2002,38(2):111～121.
